BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8740698)

  • 21. Clinicopathological study of canine transmissible venereal tumour in leishmaniotic dogs.
    Marino G; Gaglio G; Zanghì A
    J Small Anim Pract; 2012 Jun; 53(6):323-7. PubMed ID: 22489831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
    Mukaratirwa S; Gruys E
    Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor.
    Chiang HC; Wang YS; Chou CH; Liao AT; Chu RM; Lin CS
    BMC Vet Res; 2012 Nov; 8():216. PubMed ID: 23136963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression.
    Hsiao YW; Liao KW; Chung TF; Liu CH; Hsu CD; Chu RM
    Cancer Immunol Immunother; 2008 Jul; 57(7):1091-104. PubMed ID: 18259750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex disparity in oronasal presentations of canine transmissible venereal tumour.
    Strakova A; Baez-Ortega A; Wang J; Murchison EP
    Vet Rec; 2022 Sep; 191(5):e1794. PubMed ID: 35781651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Observations on the transmissible venereal tumor (sticker) in the dog. A review of the tumors sent into the Institute for Animal Pathology of Ludwig-Maximilian University, Munich, from 1975 to 1987].
    Laging C; Kröning T
    Tierarztl Prax; 1989; 17(1):85-7. PubMed ID: 2470163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of canine transmissible venereal tumor cells using in situ polymerase chain reaction and the stable sequence of the long interspersed nuclear element.
    Liao KW; Lin ZY; Pao HN; Kam SY; Wang FI; Chu RM
    J Vet Diagn Invest; 2003 Sep; 15(5):399-406. PubMed ID: 14535538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of MHC expression and retention of ultrastructural characteristics by xenograft transmissible venereal tumor cells in SCID mice.
    Harmelin A; Pinthus JH; Friedmann-Morvinski D; Kaufman K; Brenner O
    Vet Immunol Immunopathol; 2002 Jul; 86(3-4):245-9. PubMed ID: 12007890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical staining patterns of canine meningiomas and correlation with published immunophenotypes.
    Barnhart KF; Wojcieszyn J; Storts RW
    Vet Pathol; 2002 May; 39(3):311-21. PubMed ID: 12014495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunohistochemical study of the inflammatory infiltrate associated with nasal carcinoma in dogs and cats.
    Vanherberghen M; Day MJ; Delvaux F; Gabriel A; Clercx C; Peeters D
    J Comp Pathol; 2009 Jul; 141(1):17-26. PubMed ID: 19362315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canine transmissible venereal tumor and seminoma: a cytohistopathology and chemotherapy study of tumors in the growth phase and during regression after chemotherapy.
    Javanbakht J; Pedram B; Taheriyan MR; Khadivar F; Hosseini SH; Abdi FS; Hosseini E; Moloudizargari M; Aghajanshakeri SH; Javaherypour S; Shafiee R; Emrani Bidi R
    Tumour Biol; 2014 Jun; 35(6):5493-500. PubMed ID: 24557542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid.
    Pai CC; Kuo TF; Mao SJ; Chuang TF; Lin CS; Chu RM
    Vet Immunol Immunopathol; 2011 Feb; 139(2-4):187-99. PubMed ID: 21051091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP53 Polymorphisms allow for genetic sub-grouping of the canine transmissible venereal tumor.
    Sánchez-Servín A; Martínez S; Córdova-Alarcon E; Fajardo R
    J Vet Sci; 2009 Dec; 10(4):353-5. PubMed ID: 19934603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical identification of myoepithelial, epithelial, and connective tissue cells in canine mammary tumors.
    Destexhe E; Lespagnard L; Degeyter M; Heymann R; Coignoul F
    Vet Pathol; 1993 Mar; 30(2):146-54. PubMed ID: 7682367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferation characteristics of canine transmissible venereal tumor.
    Chu RM; Lin CY; Liu CC; Yang SY; Hsiao YW; Hung SW; Pao HN; Liao KW
    Anticancer Res; 2001; 21(6A):4017-24. PubMed ID: 11911286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The T963C mutation of TP53 gene does not participate in the clonal origin of canine TVT.
    Vázquez-Mota N; Simón-Martínez J; Córdova-Alarcon E; Lagunes L; Fajardo R
    Vet Res Commun; 2008 Feb; 32(2):187-91. PubMed ID: 17668284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical determination of estrogen receptor-alpha in vaginal and tumor tissues of healthy and TVT-affected bitches and their relation to serum concentrations of estradiol-17beta and progesterone.
    de Brito CP; de Oliveira CM; Soares FA; Faustino M; de Oliveira CA
    Theriogenology; 2006 Oct; 66(6-7):1587-92. PubMed ID: 16483645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytologic subtypes of canine transmissible venereal tumor.
    Flórez MM; Pedraza F; Grandi F; Rocha NS
    Vet Clin Pathol; 2012 Mar; 41(1):4-5. PubMed ID: 22390421
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunohistochemical identification of lysozyme and vimentin in an experimental malignant fibrous histiocytoma.
    Ribeiro RA; Fonteles MC; Zucoloto S; Bacchi CE
    Braz J Med Biol Res; 1988; 21(5):995-7. PubMed ID: 2854748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive conservation of genomic imbalances in canine transmissible venereal tumors (CTVT) detected by microarray-based CGH analysis.
    Thomas R; Rebbeck C; Leroi AM; Burt A; Breen M
    Chromosome Res; 2009; 17(7):927-34. PubMed ID: 19798471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.